Forging public-private partnerships with academia, industry, government and public health is essential to bringing innovative vaccine technologies to the market
Advancing Canada’s promising vaccine discoveries of public health importance through preclinical to Phase l and/or early-Phase ll clinical evaluation
Through support of Canadian partners, PREVENT will achieve commercialization success and generate dependable revenue streams to ensure long-term sustainability
PREVENT fosters a unique learning environment by bringing together internationally recognized expertise and substantial teaching experience in vaccinology and commercialization
Pan-Provincial Vaccine Enterprise Inc. (PREVENT) is a national Centre of Excellence for Commercialization and Research (CECR), a not-for-profit organization focused on the development of vaccine technologies
the growth of Canada’s vaccine industry by establishing comprehensive preclinical and early clinical programs for the development of new or improved vaccines of high public health importance
Canada’s presence at the forefront of vaccine development by fostering partnerships among academic, industry, government, and not-for-profit sectors to mobilize expertise in areas of vaccine commercialization
Canada’s vaccine research and development by identifying promising vaccine technologies from Canadian academia and biotech and cultivating them into attractive candidates for commercialization